ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
Neuren FDA meeting confirms Phase 3 plan for Rett syndrome
Published: 13/10/17, 08:59am (AEST)•1 pages